Opening day two of the 2026 WDC China Summit, Lenny Shallcross said: “From blood-based diagnostics to the first disease-modifying treatments, yesterday captured a field that is moving quickly, and a room that believes the progress is real.”

From policy to action: in the plenary on biomarkers and readiness for clinical use, Yi Tang outlined China’s approach to dementia prevention, early detection and health-system transformation.

We’re underway in Guangzhou. 📍 The 2026 WDC China Summit opens with a plenary on the science of disease, the start of two days on turning advances in dementia science into routine clinical practice across China and beyond. Learn more: bit.ly/WDCchina2026

In case you missed it: leaders of dementia organisations in Australia, Canada, the Netherlands, the UK and the US shared what is working, and what is not, in advocating for treatment access. Read the World Dementia Council’s update for @alzdemjournals.bsky.social: bit.ly/4A0vTwL

How are advocacy movements making the case for biomarkers in health systems? 🌍 On 1 Dec., the World Dementia Council brings together leaders of advocacy organisations from around the world for a virtual exchange on advocacy in the era of treatments. Learn more: bit.ly/WDCGlobalLeaders

The 2026 WDC China Summit opens Saturday in Guangzhou. 📍 Across two days, clinicians, researchers and health system leaders will examine clinical guidelines on biomarkers, lessons from early treatment delivery, prevention and data for long-term care. Learn more: bit.ly/WDCchina2026

The first treatments and new diagnostics are changing who the patient is. Picking up the 2026 WDC Summit theme, a WDC virtual dialogue on 24 Nov. explores what that means for care and support, with speakers from @alzassociation.bsky.social and ADI. Learn more: bit.ly/4znZPTx

The October WDC update is published in @alzdemjournals.bsky.social 🌍 It summarises our Global Advocacy Leaders Exchange, where dementia organisations from five countries shared how they are moving new diagnostics and treatments from approval to patients. bit.ly/4A0vTwL

What would it take to make brain health a lasting priority in Latin America? 🧠 The transcript from our Buenos Aires meeting with @alzassociation.bsky.social is now available, including how U.S. POINTER and LatAm-FINGERS are reaching communities. Read: bit.ly/48bdOjB

We’re glad to be back at #36AEC. Thank you to Jean Georges for all he has done to move Alzheimer’s disease and dementia progress forward.

Alzheimer Europe@alzheimereurope.bsky.social · 3w ago

During KN01. at #36AEC, Jean Georges, Executive Director of Alzheimer Europe, explores the power of partnership in advancing dementia policy, research and support. 💬Read Jean's message.👇 📖 Programme: bit.ly/36AEC_Progra...

What does moving anti-amyloid therapy into practice look like in India? WDC and @alzassociation.bsky.social are partnering with the Cognitive Neurology Association on its second annual summit in Bengaluru, Nov. 20-22, with a WDC roundtable on biomarkers. Learn more: bit.ly/IndiaSummit2026

Three weeks until the 2026 WDC China Summit in Guangzhou. 📍 Building on the 2024 Summit, the programme looks at how updated diagnostic criteria, biomarkers, treatment and data can be turned into practical pathways and service models for dementia care. Learn more: bit.ly/WDCchina2026

Dementia policy is moving from “if” to “how.” Treatments, earlier diagnosis and prevention have arrived; the task now is making them work for the people who need them. Lenny Shallcross, WDC Executive Director, on the moment and our six new members: bit.ly/2026memberdispatch

As the 2026 WDC Summit at the Francis Crick Institute concludes, thank you to our speakers, chairs and attendees for a day of discussion on The New Patient: Before Symptoms, After Diagnosis.

The 2026 World Dementia Council Summit is being held today at the Francis Crick Institute in London. Speakers will explore The New Patient: Before Symptoms, After Diagnosis, and what the move to earlier detection and treatment means for people and health systems.

We welcomed six new members to the World Dementia Council today. Their work spans biomarkers, clinical care, prevention trials and the safety of new treatments, across Europe, Asia, Latin America and the United States. Read more: bit.ly/2026NewMembers

Science into clinical practice. 📍 The 2026 WDC China Summit in Guangzhou, Nov. 14-15, convenes clinicians, researchers and health system leaders from China and beyond on biomarkers, early treatment delivery, prevention and data for long-term care. Learn more: bit.ly/WDCchina2026

One week until the WDC Summit. 📅 On Oct. 20 at the Francis Crick Institute, international and UK leaders examine what earlier diagnosis, new treatments and prevention mean for clinical pathways, health systems and people living with an early diagnosis. Learn more: bit.ly/40bH0mO

Treatments are arriving, diagnosis is moving earlier and health priorities are shifting. The World Dementia Council is convening in London, Guangzhou and Bengaluru this autumn, with December virtual dialogues on treatments, AI, advocacy and the new patient. Learn more: bit.ly/4sFS0p9

Earlier detection raises questions the field has not had to answer before: how to communicate risk responsibly, how to organise sustained support, how to make sure detection leads to better outcomes. All on the agenda at the WDC Summit, Oct. 20 in London. bit.ly/40bH0mO

As diagnosis moves earlier, sometimes before symptoms, people arrive at dementia services with different needs. On Oct. 20, the WDC Summit, “The New Patient: Before symptoms, after diagnosis,” convenes international and UK leaders at the Francis Crick Institute. Learn more: bit.ly/40bH0mO

Biomarkers, digital testing, remote monitoring, AI. The World Dementia Council update in @alzdemjournals.bsky.social looks at what has to be validated, financed and scaled if earlier detection of Alzheimer's is to reach health systems with very different resources: bit.ly/46JTlBZ

As diagnostics and treatment for Alzheimer’s disease advance, health systems face new questions on equitable access, workforce and long-term support. The World Dementia Council will explore these at the 2026 Summit in London. Learn more: bit.ly/40bH0mO

World Alzheimer's Day is a global moment to raise awareness for the more than 55 million people worldwide living with Alzheimer's and dementia, and the carers who support them. The World Dementia Council remains committed to advancing progress on their behalf. #WorldAlzheimersDay

Two days that gave the region a great deal to work with. Thank you to @alzassociation.bsky.social for building this with us, and to everyone who travelled to Buenos Aires or joined online. The evidence is in. The work of delivering it starts now.

Alzheimer's Association@alzassociation.bsky.social · 2mo ago

Thank you to the researchers, health professionals and health system leaders from around the world who joined us and the @worlddementia.bsky.social in Buenos Aires to discuss how to put evidence-based lifestyle intervention programs into practice. We're excited about the future of brain health.

This week we are in Buenos Aires for Brain Health and Cognition in Latin America, a meeting we are holding with @alzassociation.bsky.social. LatAm-FINGERS showed a multidomain lifestyle programme can work across 11 countries. The question now is what it takes to reach health systems.

The 2026 World Dementia Council Summit will bring senior leaders from government, research, philanthropy, health care and industry to London this October to shape policy on Alzheimer’s diagnosis, treatment and dementia care. Learn more: bit.ly/40bH0mO

Science is no longer the field's central constraint. Delivery is. The World Dementia Council update in @alzdemjournals.bsky.social reports on the advocacy breakfast held alongside AAIC in London, and what it will take to reach people with new treatments and care. Read July's update: bit.ly/4qP6brO

World Dementia Council Update

Click on the article title to read more.

bit.ly

Alzheimer’s disease is increasingly detectable before symptoms appear. At the 2026 Summit, “The New Patient: Before symptoms, after diagnosis,’’ the World Dementia Council will examine what this shift means for diagnosis, care and support systems worldwide. Learn more: bit.ly/40bH0mO

Health systems in the US, Japan, China and Israel have managed new Alzheimer’s treatments without being overwhelmed. The World Dementia Council’s update for @alzdemjournals.bsky.social looks at why that real-world evidence isn’t yet shifting reimbursement decisions across Europe: bit.ly/4hzZHKA